Viewing Study NCT03824795


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-01-18 @ 6:34 PM
Study NCT ID: NCT03824795
Status: COMPLETED
Last Update Posted: 2020-04-15
First Post: 2019-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD
Sponsor: MGB Biopharma Limited
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1011464
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View